PanGen Biotech Inc. (KOSDAQ: 222110)

PanGen Biotech Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 14, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	73,444	73,462	69,405	99,783	97,864	74,917
Market Cap Growth	-23.33%	5.85%	-30.44%	1.96%	30.63%	-26.00%
Enterprise Value	69,738	74,767	67,446	92,638	96,121	65,917
Last Close Price	6400.00	6880.00	6500.00	9350.00	10150.00	7770.00
Forward PE	-	91.30	91.30	91.30	91.30	91.30
PS Ratio	5.16	10.04	10.68	12.57	15.81	26.00
PB Ratio	4.06	5.85	4.03	4.73	6.89	4.07
P/TBV Ratio	2.71	6.29	4.09	4.80	7.02	4.13
EV/Sales Ratio	5.08	10.22	10.38	11.67	15.53	22.88
Debt / Equity Ratio	0.13	0.16	0.00	0.89	1.29	0.94
Debt / EBITDA Ratio	1.60	-	-	-	-	-
Asset Turnover	0.57	0.35	0.20	0.20	0.16	0.07
Inventory Turnover	1.17	0.94	1.06	1.82	2.12	7.79
Quick Ratio	1.63	0.42	1.55	1.28	0.97	1.30
Current Ratio	3.30	1.72	7.59	1.57	1.20	1.35
Return on Equity (ROE)	-3.65%	-30.14%	-23.46%	-18.75%	-26.69%	-39.40%
Return on Assets (ROA)	-0.18%	-12.75%	-8.97%	-5.16%	-6.14%	-11.77%
Return on Capital (ROIC)	-0.23%	-16.61%	-10.06%	-5.68%	-6.76%	-12.64%
Earnings Yield	-0.85%	-6.11%	-6.47%	-3.32%	-4.45%	-11.93%
FCF Yield	0.58%	-5.27%	-6.10%	-4.76%	-5.56%	-5.98%
Buyback Yield / Dilution	-3.72%	-0.03%	-4.47%	-6.02%	0.04%	-0.16%
Total Shareholder Return	-3.72%	-0.03%	-4.47%	-6.02%	0.04%	-0.16%

Source: S&P Capital IQ. Standard template. Financial Sources.